AIDX
20/20 Biolabs, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.23
−0.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.99x
- Price / sales
- 1.54x
- Price / cash flow
- -1.12x
Enterprise value
- Enterprise value
- $704.9K
- EV / sales
- 0.35x
- EV / EBITDA
- -0.15x
- EV / EBIT
- -0.16x
- Market cap
- $3.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026